• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.

作者信息

Overgaard J, von der Maase H, Overgaard M

出版信息

Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1837-9. doi: 10.1016/0360-3016(85)90042-2.

DOI:10.1016/0360-3016(85)90042-2
PMID:4044346
Abstract

Thirty-five tumors in 14 patients with metastatic or recurrent malignant melanoma were randomized to high dose per fraction radiotherapy at either 9 Gy X 3 or 5 Gy X 8 twice weekly. Complete and persistent regression was found in 24/35 (69%) and partial response in 10/35 of the tumors. The overall response rate was 97%. No difference was observed between the two treatment regimens. Acute and late radiation damage to normal tissue was acceptable and of the same magnitude in both schedules.

摘要

相似文献

1
A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.
Int J Radiat Oncol Biol Phys. 1985 Oct;11(10):1837-9. doi: 10.1016/0360-3016(85)90042-2.
2
Some factors of importance in the radiation treatment of malignant melanoma.
Radiother Oncol. 1986 Mar;5(3):183-92. doi: 10.1016/s0167-8140(86)80048-2.
3
Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic malignant melanoma. A multicentre randomized trial by the European Society for Hyperthermic Oncology.热疗作为复发性或转移性恶性黑色素瘤放射治疗的辅助手段。欧洲热疗肿瘤学会的一项多中心随机试验。
Int J Hyperthermia. 1996 Jan-Feb;12(1):3-20. doi: 10.3109/02656739609023685.
4
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.复发性和转移性恶性黑色素瘤的姑息性放疗:肿瘤反应和长期结局的预后因素:20年经验
Int J Radiat Oncol Biol Phys. 1999 Jun 1;44(3):607-18. doi: 10.1016/s0360-3016(99)00066-8.
5
Randomised trial of hyperthermia as adjuvant to radiotherapy for recurrent or metastatic malignant melanoma. European Society for Hyperthermic Oncology.热疗作为复发性或转移性恶性黑色素瘤放疗辅助治疗的随机试验。欧洲热疗肿瘤学会。
Lancet. 1995 Mar 4;345(8949):540-3. doi: 10.1016/s0140-6736(95)90463-8.
6
Adjuvant irradiation for axillary metastases from malignant melanoma.恶性黑色素瘤腋窝转移的辅助放疗。
Int J Radiat Oncol Biol Phys. 2002 Mar 15;52(4):964-72. doi: 10.1016/s0360-3016(01)02742-0.
7
Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma.热疗作为放射治疗的辅助手段用于恶性黑色素瘤的治疗。
Int J Hyperthermia. 1987 Nov-Dec;3(6):483-501. doi: 10.3109/02656738709140422.
8
Fraction size in external beam radiation therapy in the treatment of melanoma.外照射放射治疗中用于治疗黑色素瘤的分次剂量大小。
Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):429-32. doi: 10.1016/0360-3016(91)90053-7.
9
The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study.放射治疗在复发性和转移性恶性黑色素瘤中的作用:一项临床放射生物学研究。
Int J Radiat Oncol Biol Phys. 1986 Jun;12(6):867-72. doi: 10.1016/0360-3016(86)90378-0.
10
Treatment of malignant melanoma by fast neutrons.快中子治疗恶性黑色素瘤
Br J Surg. 1985 Jul;72(7):517-9. doi: 10.1002/bjs.1800720704.

引用本文的文献

1
Stereotactic ablative radiation therapy for extracranial metastases from malignant melanoma: An international multi-institutional analysis.立体定向消融放疗治疗恶性黑色素瘤的颅外转移:一项国际多机构分析。
J Radiosurg SBRT. 2025;9(3):199-205.
2
The Diagnosis and Management of Cutaneous Metastases from Melanoma.黑色素瘤皮肤转移的诊断与处理。
Int J Mol Sci. 2023 Sep 26;24(19):14535. doi: 10.3390/ijms241914535.
3
Radiotherapy in the Treatment of Subcutaneous Melanoma.放射疗法在皮下黑色素瘤治疗中的应用
Cancers (Basel). 2021 Nov 22;13(22):5859. doi: 10.3390/cancers13225859.
4
A Prospective, Phase 1 Trial of Nivolumab, Ipilimumab, and Radiotherapy in Patients with Advanced Melanoma.纳武利尤单抗、伊匹单抗联合放疗治疗晚期黑色素瘤的前瞻性 1 期临床试验。
Clin Cancer Res. 2020 Jul 1;26(13):3193-3201. doi: 10.1158/1078-0432.CCR-19-3936. Epub 2020 Mar 23.
5
Nanosystems for Improved Targeted Therapies in Melanoma.用于改善黑色素瘤靶向治疗的纳米系统
J Clin Med. 2020 Jan 23;9(2):318. doi: 10.3390/jcm9020318.
6
Radiotherapy for Melanoma: More than DNA Damage.黑色素瘤的放射治疗:不止于DNA损伤。
Dermatol Res Pract. 2019 Apr 3;2019:9435389. doi: 10.1155/2019/9435389. eCollection 2019.
7
The Clinical Trial Landscape for Melanoma Therapies.黑色素瘤疗法的临床试验概况
J Clin Med. 2019 Mar 15;8(3):368. doi: 10.3390/jcm8030368.
8
Combined radiotherapy with nivolumab for extracranial metastatic malignant melanoma.纳武利尤单抗联合放疗治疗颅外转移性恶性黑色素瘤。
Jpn J Radiol. 2018 Dec;36(12):712-718. doi: 10.1007/s11604-018-0774-8. Epub 2018 Sep 11.
9
18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma.立体定向体部放射治疗转移性黑色素瘤后的18F-FDG PET反应及临床结果
Adv Radiat Oncol. 2017 Feb 24;2(2):204-210. doi: 10.1016/j.adro.2017.02.003. eCollection 2017 Apr-Jun.
10
Avoiding Severe Toxicity From Combined BRAF Inhibitor and Radiation Treatment: Consensus Guidelines from the Eastern Cooperative Oncology Group (ECOG).避免BRAF抑制剂与放射治疗联合使用时的严重毒性:东部肿瘤协作组(ECOG)的共识指南
Int J Radiat Oncol Biol Phys. 2016 Jun 1;95(2):632-46. doi: 10.1016/j.ijrobp.2016.01.038.